Development of a vector based on natural excipient in order to reduce the therapeutic doses of current treatments and their adverse effects in chronic inflammatory bowel diseases (IBD). - Université Clermont Auvergne Accéder directement au contenu
Poster De Conférence Année : 2021

Development of a vector based on natural excipient in order to reduce the therapeutic doses of current treatments and their adverse effects in chronic inflammatory bowel diseases (IBD).

Jérémy Denizot
Ghislain Garrait
  • Fonction : Auteur
  • PersonId : 1205728
Khaled Fadhlaoui
Arthur Chevet
Frédéric Antonio Carvalho
Eric Beyssac
  • Fonction : Auteur
  • PersonId : 1203286
Fichier non déposé

Dates et versions

hal-03417146 , version 1 (05-11-2021)

Identifiants

  • HAL Id : hal-03417146 , version 1

Citer

Delanne Améline, Jérémy Denizot, Ghislain Garrait, Khaled Fadhlaoui, Arthur Chevet, et al.. Development of a vector based on natural excipient in order to reduce the therapeutic doses of current treatments and their adverse effects in chronic inflammatory bowel diseases (IBD).. Young Researchers of Auvergne Rhône Alpes Region Congress, Jun 2021, Virtual conference, France. ⟨hal-03417146⟩
26 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More